Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$39.12 -0.7 | -1.76%
10/23/14 - 02:21 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -31.18M -23.32M -18.09M
Operating Gains/Losses 2.00K 38.00K 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables -919.00K -340.00K 444.00K
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables -359.00K -700.00K 637.00K
(Decrease) Increase In Other Current Liabilities 1.25M 367.00K 276.00K
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00
Other Non-Cash Items 4.36M 3.20M 2.54M
Net Cash From Continuing Operations -25.82M -20.47M -12.95M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -25.82M -20.47M -12.95M
Sale of Property, Plant & Equipment 0.00 50.00K 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.39M -1.32M -281.00K
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00
Other Cash from Investing Activities 1.49M 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -141.00K -277.00K -502.00K
Issuance of Debt 0.00 456.00K 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 0.00 1.28M 42.57M
Repayment of Long-Term Debt -215.00K -229.00K -218.00K
Repurchase of Capital Stock 0.00 -4.00K 13.00K
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net 67.22M 0.00 0.00
Net Cash From Financing Activities 67.00M 1.51M 42.37M
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 41.04M -19.24M 28.92M

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter